How should agitation or combativeness be addressed in post-resuscitation care?

• A. Administer Midazolam 2.5 mg IV/IO or 5 mg IM
• B. Provide restraints only
• C. No sedation
• D. Haloperidol 5 mg IV

Answer: (A)

Agitation after resuscitation poses safety risks to the patient and to staff, and it can interfere with ventilation and ongoing monitoring. The best way to address this is to provide calm, controllable sedation with a short-acting agent that can be titrated and reversed if needed. Midazolam fits this role well because it has a rapid onset and multiple available routes (IV/IO for quick effect, or IM if IV access isn’t yet established), allowing you to quickly achieve a calm state and then reassess as the patient stabilizes. A small starting dose—2.5 mg IV/IO or 5 mg IM—lets you control the level of sedation and adjust as needed while monitoring respiratory status and hemodynamics.

Restraints alone do not treat the underlying agitation and can cause harm, including injury and worsening delirium. No sedation leaves the patient in a highly risky state for self-extubation, line dislodgement, or agitation-driven hypoxia. While antipsychotics like haloperidol can be used in some agitation scenarios, they carry cardiac risks (such as QT prolongation) that are particularly concerning in a recently resuscitated patient who may have electrolyte disturbances. Therefore, a short-acting benzodiazepine like midazolam is the most appropriate first-line choice in this context.